Longliv Ventures backs DayTwo

Longliv Ventures is investing $5 million in DayTwo, a microbiome human discovery platform. DayTwo's other investors include Cathay Innovation and Samsung NEXT.

ByIris Dorbian

3 October 2019•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Managers North America US Healthcare Briefs